WuXi Biologics (Cayman) Inc. WuXi Biologics (Cayman) Inc.

WuXi Biologics (Cayman) Inc.

2269

Peringkat dalam Saham #991
Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman)... Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale manufacturing. The company's operations have a global footprint, serving clients across the People's Republic of China, North America, Europe, and other international regions. Its diversified offerings also include specialized consultation in biopharmaceutical technology, international sales contracting, the development and deployment of advanced testing methodologies, and robust marketing and sales support. Furthermore, WuXi Biologics is involved in providing dedicated biologics clinical and manufacturing services, the production and distribution of various medical products, contract development and manufacturing (CDMO) for vaccines and associated businesses, and acting as a supplier of key materials. The firm maintains strategic partnerships with notable entities such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc.
Harga Saham
$5.70
Kapitalisasi Pasar
$23.45B
Perubahan (1 hari)
-9.51%
Perubahan (1 tahun)
23.58%
Negara
CN
Perdagangan WuXi Biologics (Cayman) Inc. (2269)

Kategori

Healthcare
Riwayat dividen untuk WuXi Biologics (Cayman) Inc. (2269)
Saham WuXi Biologics (Cayman) Inc. (simbol: 2269) telah membayar total 0 dividen.
Total semua dividen (disesuaikan dengan stock split): 0.00
Imbal hasil dividen (TTM): 0
Pembayaran dividen untuk WuXi Biologics (Cayman) Inc. (2269) dari 2026 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (disesuaikan dengan stock split) Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Daftar semua pembayaran dividen
Tahun Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Pembayaran dividen untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pembayaran dividen Negara
0.00%
US
0.00%
US
67.00%
AU
0.00%
NL
0.00%
CH